文献速递流行病学与生物统计真实世界研究与卫生经济

加州州保险性别非歧视法案与性别肯定手术利用的关联

Association Between California's State Insurance Gender Nondiscrimination Act and Utilization of Gender-Affirming Surgery.
PubMed 文献 · JAMA · 2023-01-01

该人群流行病学研究比较了加州2013年7月实施《保险性别非歧视法案》前后性别肯定手术利用率的变化,并与华盛顿州和亚利桑那州对照。研究发现,在参保患者中,加州实施该法案与性别肯定手术概率绝对增加12.1%(95%CI 10.3%-13.9%;P<.001)相关,而自费患者中未观察到类似增加。

要点

  • 加州实施《保险性别非歧视法案》后,参保患者性别肯定手术概率绝对增加12.1%(95%CI 10.3%-13.9%;P<.001)。
  • 自费患者中,该政策实施与性别肯定手术概率变化无显著关联(-22.6%[95%CI -32.8%至-12.5%];P<.001)。
  • 加州性别肯定手术利用率在研究期间为15.1%,对照州为2.8%。

核心结论

  • 加州实施《保险性别非歧视法案》与性别肯定手术利用率较对照州华盛顿和亚利桑那显著增加相关。
  • 这些数据或可为州立法努力提供参考,以制定政策防止居民(包括跨性别和性别多元患者)在健康保险覆盖方面受到歧视。

研究设计与样本

  • 人群流行病学研究,纳入2005年至2019年间接受性别肯定手术(面部、胸部、生殖器手术)的跨性别和性别多元患者。
  • 比较加州2013年7月实施《保险性别非歧视法案》前后性别肯定手术利用率与对照州华盛顿和亚利桑那的差异;对照州因地理相似性及与加州同日(2014年1月1日)扩大医疗补助而选择。
  • 末次随访日期为2019年12月31日。
  • 共25 252例患者被诊断为性别烦躁(加州n=17 934[71%];对照州n=7 328[29%])。
  • 加州(不论是否接受性别肯定手术)中位年龄为34.0岁;对照州接受性别肯定手术者中位年龄39岁(IQR 28-49岁),未接受者中位年龄36岁(IQR 22-56岁)。

主要发现

  • 研究期间至少接受1次性别肯定手术者共2 918例(11.6%),其中加州2 715例(15.1%),对照州203例(2.8%)。
  • 2013年7月第三季度,加州较对照州性别肯定手术出现统计学显著增加,与《保险性别非歧视法案》实施时间吻合(P<.001)。
  • 在参保患者亚组中,政策实施与加州较对照州接受性别肯定手术概率绝对增加12.1%(95%CI 10.3%-13.9%;P<.001)相关(13.4%[95%CI 11.5%-15.4%];P<.001)。
  • 在自费患者中,政策实施与接受性别肯定手术概率变化无显著关联(-22.6%[95%CI -32.8%至-12.5%];P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Gender-affirming surgery is often beneficial for gender-diverse or -dysphoric patients. Access to gender-affirming surgery is often limited through restrictive legislation and insurance policies. OBJECTIVE: To investigate the association between California's 2013 implementation of the Insurance Gender Nondiscrimination Act, which prohibits insurers and health plans from limiting benefits based on a patient's sex, gender, gender identity, or gender expression, and utilization of gender-affirming surgery among California residents. DESIGN, SETTING, AND PARTICIPANTS: Population epidemiology study of transgender and gender-diverse patients undergoing gender-affirming surgery (facial, chest, and genital surgery) between 2005 and 2019. Utilization of gender-affirming surgery in California before and after implementation of the Insurance Gender Nondiscrimination Act in July 2013 was compared with utilization in Washington and Arizona, control states chosen because of geographic similarity and because they expanded Medicaid on the same date as California-January 1, 2014. The date of last follow-up was December 31, 2019. EXPOSURES: California's Insurance Gender Nondiscrimination Act, implemented on July 9, 2013. MAIN OUTCOMES AND MEASURES: Receipt of gender-affirming surgery, defined as undergoing at least 1 facial, chest, or genital procedure. RESULTS: A total of 25 252 patients (California: n = 17 934 [71%]; control: n = 7328 [29%]) had a diagnosis of gender dysphoria. Median ages were 34.0 years in California (with or without gender-affirming surgery), 39 years (IQR, 28-49 years) among those undergoing gender-affirming surgery in control states, and 36 years (IQR, 22-56 years) among those not undergoing gender-affirming surgery in control states. Patients underwent at least 1 gender-affirming surgery within the study period in 2918 (11.6%) admissions-2715 (15.1%) in California vs 203 (2.8%) in control states. There was a statistically significant increase in gender-affirming surgery in the third quarter of July 2013 in California vs control states, coinciding with the timing of the Insurance Gender Nondiscrimination Act (P < .001). Implementation of the policy was associated with an absolute 12.1% (95% CI, 10.3%-13.9%; P < .001) increase in the probability of undergoing gender-affirming surgery in California vs control states observed in the subset of insured patients (13.4% [95% CI, 11.5%-15.4%]; P < .001) but not self-pay patients (-22.6% [95% CI, -32.8% to -12.5%]; P < .001). CONCLUSIONS AND RELEVANCE: Implementation in California of its Insurance Gender Nondiscrimination Act was associated with a significant increase in utilization of gender-affirming surgery in California compared with the control states Washington and Arizona. These data might inform state legislative efforts to craft policies preventing discrimination in health coverage for state residents, including transgender and gender-diverse patients.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Schoenbrunner A, Beckmeyer A, Kunnath N, et al. Association Between California's State Insurance Gender Nondiscrimination Act and Utilization of Gender-Affirming Surgery. JAMA. 2023. PMID: 36917051. doi:10.1001/jama.2023.0878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。